Login

Switch On Your HIV Smarts.

Long-acting injectable PrEP study now enrolling

Long-acting injectable PrEP study now enrolling

, by San Francisco AIDS Foundation

Study sites across the world are testing the effectiveness of a long-acting version of cabotegravir for PrEP. Read More

Penis bacteria linked to HIV acquisition

Penis bacteria linked to HIV acquisition

, by Emily Newman

Read why the colonies of bacteria that populate the foreskin affect HIV risk, and how circumcision modifies risk. Read More

New antibody therapy “profoundly” successful at reducing inflammation from HIV

New antibody therapy “profoundly” successful at reducing inflammation from HIV

, by Emily Newman

With just one dose, canakinumab reduced markers of inflammation and improved arterial function in people living with HIV. Read More

With healthcare for millions at stake, Republicans unveil flawed, cost-cutting Affordable Care Act replacement

With healthcare for millions at stake, Republicans unveil flawed, cost-cutting Affordable Care Act replacement

, by Emily Newman

Policy experts explain what the effects of the proposed replacement bill might be for people living with HIV. Read More

PrEP study now enrolling at Strut in San Francisco

PrEP study now enrolling at Strut in San Francisco

, by San Francisco AIDS Foundation

San Francisco AIDS Foundation is enrolling people into a study testing an investigational new drug for PrEP. Find out what the study’s about, and how to get involved. Read More